Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell gene regulatory network prediction by explainable AI. | Nucleic Acids Res | 2023 | 36629274 | PubTator, text mining | PubMed |
| DNA fragility at the KMT2A/MLL locus: insights from old and new technologies. | Open Biol | 2023 | 36629017 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7. | Cureus | 2023 | 36628390 | PubTator, text mining | PubMed |
| A TRIP11:: FLT3 gene fusion in a patient with myeloid/lymphoid neoplasm with eosinophilia and tyrosine kinase gene fusions: a case report and review of the literature. | Cold Spring Harb Mol Case Stud | 2023 | 36627146 | PubTator, text mining | PubMed |
| Cell-type-specific prediction of 3D chromatin organization enables high-throughput in silico genetic screening. | Nat Biotechnol | 2023 | 36624151 | PubTator, text mining | PubMed |
| Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets. | Biosci Rep | 2023 | 36622782 | PubTator, text mining | PubMed |
| A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia. | Anticancer Drugs | 2023 | 36622759 | PubTator, text mining | PubMed |
| Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML. | Blood Cancer J | 2023 | 36599822 | PubTator, text mining | PubMed |
| Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Cancer Discov | 2023 | 36598417 | PubTator, text mining | PubMed |
| The Clinical and Molecular Spectrum of Trichorhinophalangeal Syndrome Types I and II in a Turkish Cohort Involving 22 Patients. | Turk Arch Pediatr | 2023 | 36598218 | PubTator, text mining | PubMed |
| Role of primary aging hallmarks in Alzheimer´s disease. | Theranostics | 2023 | 36593969 | PubTator, text mining | PubMed |
| Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. | Immunol Rev | 2023 | 36588481 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers dynamic roadmap and cell-cell communication during buffalo spermatogenesis. | iScience | 2023 | 36582818 | PubTator, text mining | PubMed |
| Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. | Ann Hematol | 2023 | 36576532 | PubTator, text mining | PubMed |
| How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms. | Clin Hematol Int | 2023 | 36574201 | PubTator, text mining | PubMed |
| α-Kleisin subunit of cohesin preserves the genome integrity of embryonic stem cells. | BMB Rep | 2023 | 36571142 | PubTator, text mining | PubMed |
| Proteomics reveals that cell density could affect the efficacy of drug treatment. | Biochem Biophys Rep | 2023 | 36561432 | PubTator, text mining | PubMed |
| Diverse silent chromatin states modulate genome compartmentalization and loop extrusion barriers. | Nat Struct Mol Biol | 2023 | 36550219 | PubTator, text mining | PubMed |
| The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma. | Cancer Sci | 2023 | 36541483 | PubTator, text mining | PubMed |
| Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report. | Thorac Cancer | 2023 | 36495048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=30